Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders Volume 1, 2000 - Issue 3
Journal homepage
11
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Editorial and Guest Editorials

Pages 139-141 | Published online: 10 Jul 2009

  • Simonian NA, Hyman BT. Functional alterations in Alzheimer's disease: diminution of cytochrome C oxidase in the hippocampal formation. J Neuropathol Exp Neurol 1993; 52: 580-585.
  • Mizuno Y, Yoshino H, Ikebe S-I, et al. Mitochondrial dysfunction in Parkinson's disease. Ann Neurol 1998; 44 (Suppl 1): S99-S109.
  • Ono S, Toyokura Y, Mannen T, Ishibashi Y. "Delayed return phenomenon" in amyotrophic lateral sclerosis. Acta Neurologica Scandinavia 1988; 77: 102-107.
  • Ono S, Nagao K, Yamauchi M. Amorphous material of skin in amyotrophic lateral sclerosis. Neurology 1994; 44: 537-540.
  • Ono S, Imai T, Yamauchi M, Nagao K Hyaluronic acid is increased in the skin and urine in patients with amyotrophic lateral sclerosis. J Neural 1996; 243: 693-699.
  • Ono S, Imai T, Aso A, Yamano T, Shimizu N, Nagao K. Alterations of skin glycosaminoglycans in patients with amyotrophic lateral sclerosis. Neurology 1998; 51: 399-404.
  • Ono S. The skin in amyotrophic lateral sclerosis. ALS 2000; 1: 191-199.
  • Ono S, Imai T, Tsumura M, et al. Increased serum hyaluronic acid in ALS: Relation to its skin content. ALS 2000; 1: 213-218.
  • Evans OB, Parke CC, Haas RH, Naidu S, Moser HW, Bock H-C. Inborn errors of metabolism of the nervous system. In Bradley WC, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in Clinical Practice. 3rd Ed. Butterworth-Heinemann: Boston, 2000.
  • ALS CNTT Treatment Study Croup. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rCNTF) in amyotrophic lateral sclerosis. Neurology 1996; 46: 1244-1249.
  • Aebischer P, Schluep M, Déglon N, et al. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nature Med 1996; 2: 696-699.
  • Lai EC, Felice KJ, Festoff BW, et al, and the North America ALS/IGF-I Study Croup. Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. Neurology 1997; 49: 1621-1630.
  • The BDNF Study Croup (Phase III). A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 1999; 52: 1427-1433.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.